About Apogee Therapeutics, Inc. 
Apogee Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 58 Schemes (49.87%)
Foreign Institutions
Held by 110 Foreign Institutions (16.15%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-69 Million
Pharmaceuticals & Biotechnology
USD 4,940 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.89
-43.26%
8.42






